Explore Comprehensive Drug Information from A to Z and the Latest Health News: Your Guide to Safe Health at Your Fingertips

Detailed and accurate information is provided on over 24,000 prescription and over-the-counter medicines for both consumers and healthcare professionals.

Popular drug searches

Latest Health News

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Pasithea Therapeutics Corp. (NASDAQ KTTA) ( Pasithea or the Company ), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Phase III Study Results with Bayer’s FXIa Inhibitor Asundexian Demonstrating Substantial Reduction in Ischemic Stroke with No Increase in ISTH Major Bleeding Versus Placebo Published in New England Journal of Medicine

Berlin, April 16, 2026 Bayer today announced the publication of the full results from the global, pivotal Phase III OCEANIC-STROKE study in The New England Jour

Phase III Study Results with Bayer’s FXIa Inhibitor Asundexian Demonstrating Substantial Reduction in Ischemic Stroke with No Increase in ISTH Major Bleeding Versus Placebo Published in New England Journal of Medicine

Etavopivat is the First in a New Class of Drugs to Meet Both Co-Primary Endpoints in the Phase 3 HIBISCUS Trial, Substantially Reducing Vaso-Occlusive Crisis Events and Improving Hemoglobin Response in Sickle Cell Disease

Bagsv rd, Denmark, 20 April 2026 Novo Nordisk today announced the topline results from HIBISCUS, a pivotal phase 3 trial of once-daily oral etavopivat in adults

Etavopivat is the First in a New Class of Drugs to Meet Both Co-Primary Endpoints in the Phase 3 HIBISCUS Trial, Substantially Reducing Vaso-Occlusive Crisis Events and Improving Hemoglobin Response in Sickle Cell Disease

Tozorakimab Met Primary Endpoint in Phase III MIRANDA Trial in Patients with COPD

Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically significant and cl

Tozorakimab Met Primary Endpoint in Phase III MIRANDA Trial in Patients with COPD

Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show

MONDAY, April 20, 2026 The overdose-reversing drug naloxone has been rightly hailed as a lifesaving breakthrough, saving countless lives from opioid ODs. But a

Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
Read more latest health news

Living Healthy Tips

9 Best Foods to Try

Did you eat your seaweed today? DrugsLib tells why it’s one of the lesser-known health-boosting foods.

9 Best Foods to Try

The dentist says it’s time to have your wisdom teeth removed. What should you expect?

Anxiety in Teens: What to Know

While all teens feel anxiety from time to time, some feel it more than others. DrugsLib explains how anxiety can be treated.

Anxiety in Teens: What to Know

DrugsLib offers strength training and weight lifting tips for teens.

Wondering if you might be pregnant? Look out for these early symptoms that could mean you're expecting. Learn more about the signs of pregnancy in this guide.

DrugsLib explains kennel cough, including how it is transmitted to dogs, symptoms, causes, treatments, and prevention.

Craft a healthy grocery list quickly! Find out how to build a budget-friendly grocery list that fills your meals with nutritious options.

What are some developmental milestones your child should have reached by 18 months?

Prostatitis, an inflamed and painful prostate gland, is a common condition. Learn some of the causes, symptoms and treatment of this condition.

My TK2d Diagnosis Story

A TK2d diagnosis is scary, but life with TK2d is doable thanks to the new treatment Kygevvi. Here's what one family wants you to know about this condition.

My TK2d Diagnosis Story
Read more living healthy tips

Popular Keywords